id: NEW:alcohol_related_steatosis_to_liver_failure_cirrhosis_hospitalization
name: Alcohol-Related Steatosis â†’ Liver Cirrhosis
from_node:
  node_id: NEW:alcohol_related_steatosis
  node_name: Alcohol-Related Steatosis
to_node:
  node_id: liver_failure_cirrhosis_hospitalization
  node_name: Liver Cirrhosis
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Chronic alcohol consumption leads to alcohol-related steatosis (fatty liver),
  characterized by fat accumulation in hepatocytes'
- 'Step 2: Continued alcohol exposure in the presence of steatosis promotes oxidative
  stress, lipid peroxidation, and inflammatory cytokine release'
- 'Step 3: Persistent inflammation can progress to alcohol-related steatohepatitis
  (ASH) with hepatocyte injury and immune cell infiltration'
- 'Step 4: Repeated cycles of injury and repair activate hepatic stellate cells, leading
  to progressive fibrosis'
- 'Step 5: Progressive fibrosis ultimately results in cirrhosis with architectural
  distortion, nodule formation, and impaired liver function'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Richard Parker 2020. The natural history of alcohol-related liver
    disease. Current opinion in gastroenterology.
  supporting_citations: []
description: Alcohol-related steatosis represents the most common and earliest stage
  of alcohol-related liver disease (ArLD). While associated with a relatively low
  annual progression rate to cirrhosis (approximately 3% per year), it serves as the
  necessary precursor stage in the disease continuum. The progression involves ongoing
  hepatocyte injury, inflammation, and fibrogenesis that can ultimately lead to cirrhosis.
  Notably, patients with alcohol-related steatosis have higher rates of non-liver-related
  morbidity (4% per year) compared to liver-related complications (1% per year), but
  progression to cirrhosis significantly worsens outcomes.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 3.0
    type: incidence_rate
    ci_lower: null
    ci_upper: null
  p_value: null
  sample_size: null
moderators:
- name: Obesity
  direction: strengthens
  strength: strong
  description: Obesity is the most common comorbid factor that lowers the threshold
    for alcohol-related liver disease development and accelerates progression
- name: Continued alcohol consumption
  direction: strengthens
  strength: strong
  description: Ongoing alcohol use above threshold levels promotes disease progression
    from steatosis to more advanced stages
- name: Presence of steatohepatitis
  direction: strengthens
  strength: strong
  description: Alcohol-related steatohepatitis indicates more active disease with
    higher rates of progression to cirrhosis compared to simple steatosis
